[go: up one dir, main page]

WO2003090600A3 - Compositions and methods for the diagnosis and treatment of tumor - Google Patents

Compositions and methods for the diagnosis and treatment of tumor Download PDF

Info

Publication number
WO2003090600A3
WO2003090600A3 PCT/US2002/012619 US0212619W WO03090600A3 WO 2003090600 A3 WO2003090600 A3 WO 2003090600A3 US 0212619 W US0212619 W US 0212619W WO 03090600 A3 WO03090600 A3 WO 03090600A3
Authority
WO
WIPO (PCT)
Prior art keywords
compositions
tumor
diagnosis
treatment
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2002/012619
Other languages
French (fr)
Other versions
WO2003090600A2 (en
Inventor
Avi J Ashkenazi
Dan L Eaton
Audrey Goddard
Austin L Gurney
William I Wood
Thomas D Wu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genentech Inc
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Priority to PCT/US2002/012619 priority Critical patent/WO2003090600A2/en
Priority to AU2002303430A priority patent/AU2002303430A1/en
Publication of WO2003090600A2 publication Critical patent/WO2003090600A2/en
Publication of WO2003090600A3 publication Critical patent/WO2003090600A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3015—Breast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

The present invention is directed to compositions of matter useful for the diagnosis and treatment of tumor in mammals and to methods of using those compositions of matter for the same.
PCT/US2002/012619 2002-04-23 2002-04-23 Compositions and methods for the diagnosis and treatment of tumor Ceased WO2003090600A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PCT/US2002/012619 WO2003090600A2 (en) 2002-04-23 2002-04-23 Compositions and methods for the diagnosis and treatment of tumor
AU2002303430A AU2002303430A1 (en) 2002-04-23 2002-04-23 Compositions and methods for the diagnosis and treatment of tumor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2002/012619 WO2003090600A2 (en) 2002-04-23 2002-04-23 Compositions and methods for the diagnosis and treatment of tumor

Publications (2)

Publication Number Publication Date
WO2003090600A2 WO2003090600A2 (en) 2003-11-06
WO2003090600A3 true WO2003090600A3 (en) 2004-08-19

Family

ID=29268416

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2002/012619 Ceased WO2003090600A2 (en) 2002-04-23 2002-04-23 Compositions and methods for the diagnosis and treatment of tumor

Country Status (2)

Country Link
AU (1) AU2002303430A1 (en)
WO (1) WO2003090600A2 (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5846545A (en) * 1992-03-25 1998-12-08 Immunogen, Inc. Targeted delivery of cyclopropylbenzindole-containing cytotoxic drugs
WO2000061756A2 (en) * 1999-04-09 2000-10-19 Corixa Corporation Compounds for immunotherapy and diagnosis of breast cancer and methods for their use
WO2000073454A1 (en) * 1999-06-02 2000-12-07 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5846545A (en) * 1992-03-25 1998-12-08 Immunogen, Inc. Targeted delivery of cyclopropylbenzindole-containing cytotoxic drugs
WO2000061756A2 (en) * 1999-04-09 2000-10-19 Corixa Corporation Compounds for immunotherapy and diagnosis of breast cancer and methods for their use
WO2000073454A1 (en) * 1999-06-02 2000-12-07 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
BORREBAECK: "Antibody engineering", 1992, article GILLIES S.D.: "Design of expression vectors and mammalian cell sustems suitable for engineered antibody", pages: 139 *
BORREBAECK: "Antibody engineering", 1992, article WARD E.S.: "Expression and purification of antibody fragments using Escherichia coli as host", pages: 121 *
HARRIS ET AL: "Therapeutic antibodies - the coming of age", TIBTECH, vol. 11, February 1993 (1993-02-01), pages 42 - 44, XP000561907 *

Also Published As

Publication number Publication date
WO2003090600A2 (en) 2003-11-06
AU2002303430A1 (en) 2003-11-10
AU2002303430A8 (en) 2003-11-10

Similar Documents

Publication Publication Date Title
WO2003088808A3 (en) Compositions and methods for the diagnosis and treatment of tumor
WO2003024392A3 (en) Compositions and methods for the diagnosis and treatment of tumor
WO2003000113A3 (en) Compositions and methods for the diagnosis and treatment of tumor
WO2002016429A3 (en) Compositions and methods for the diagnosis and treatment of tumor
WO2006029183A3 (en) Compositions and methods for the diagnosis and treatment of tumor
MXPA05005107A (en) Compositions and methods for the diagnosis and treatment of tumor.
WO2004112829A3 (en) Compositions and methods for the diagnosis and treatment of tumors of glial origin
WO2007001851A3 (en) Compositions and methods for the diagnosis and treatment of tumor
EP2067472A8 (en) Compositions and methods for the diagnosis and treatment of tumor
WO2002016581A3 (en) Compositions and methods for the diagnosis and treatment of tumor
WO2004030615A8 (en) Compositions and methods for the diagnosis and treatment of tumor
WO2004016225A8 (en) Compositions and methods for the diagnosis and treatment of tumor
EP1571968A3 (en) Compositions and methods for the diagnosis and treatment of tumor
WO2004060270A8 (en) Compositions and methods for the diagnosis and treatment of tumor
EP1572091A3 (en) Compositions and methods for the diagnosis and treatment of tumor
WO2005049075A3 (en) Compositions and methods for the treatment of tumor of hematopoietic origin
WO2004024063A3 (en) Compositions and methods for the diagnosis and treatment of tumor
AU2003290605A1 (en) Compositions and methods for the diagnosis and treatment of sepsis
WO2002016602A3 (en) Compositions and methods for the diagnosis and treatment of tumor
WO2005063299A3 (en) Compositions and methods for the treatment of tumor of hematopoietic origin
WO2004096124A3 (en) Compositions and methods for the diagnosis and treatment of tumor
WO2006110760A3 (en) Compositions and methods for the diagnosis and treatment of tumor
MXPA05008293A (en) Compositions and methods for the diagnosis and treatment of tumor.
WO2004019857A3 (en) Achaete-scute like-2 polypeptides and encoding nucleic acids and methods for the diagnosis and treatment of tumor
MXPA03001644A (en) Compositions and methods for the diagnosis and treatment of tumor.

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP